Using brain-computer interfaces to identify color vision issues in Parkinson's disease patients
Official title: Brain-computer interface (BCI)-based identification of color vision deficiencies (CVDs) related to Parkinson’s Disease (PD)
Funded at Albany Research Institute, INC. · NIH-11162312 · Data updated 2026-11-12
This study is looking at how special technology can help find color vision problems in people with Parkinson's disease, making it easier to spot these issues early and improve care for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Research Institute, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | August 6, 2024 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $170,000 |
| NIH project number | 5R21EB036221-02 |
| Project ID | NIH-11162312 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease or those exhibiting early signs of the condition.
✕Less likely to help
Patients without Parkinson's disease or significant cognitive and motor impairments may not benefit from this research.
What this research studies
This research investigates how brain-computer interfaces (BCIs) can be used to detect color vision deficiencies (CVDs) in individuals with Parkinson's disease (PD). The study aims to develop a new assessment method that is more sensitive and reliable than current approaches, which often fail to accommodate the cognitive and motor challenges faced by PD patients. By identifying CVDs early, the research hopes to provide insights into the prodromal stages of PD, potentially leading to earlier diagnosis and intervention. Participants will undergo BCI-based assessments to evaluate their color vision capabilities.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of Parkinson's disease, improving treatment outcomes and quality of life for patients.
How similar studies have gone: While the use of brain-computer interfaces in clinical assessments is a novel approach, similar methodologies have shown promise in other areas of cognitive and sensory evaluation.
Where this research is happening
-
Albany Research Institute, INC.
Albany, United States Active
Researchers
- Principal investigator: Norton, James John Stanley — Albany Research Institute, INC.
- Study coordinator: Norton, James John Stanley
Related research
Other NIH-funded projects on the same topics.
-
Using brain-computer signals to detect color-vision changes linked to Parkinson's
This project uses a noninvasive brain-computer interface test to find color-vision changes that could signal Parkinson’s disease in people with or at risk for PD.
-
Gut-brain clues in Parkinson’s disease: supplement to a large registry
A plant-wide supplement to an NIH program will enroll people with Parkinson’s, with and without GI symptoms, plus healthy controls, to study how gut function, brain signals, and sleep rhythms relate to Parkinson’s symptoms.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
-
Gut-brain communication in Parkinson’s disease for better symptoms and daily life
This project enrolls people with Parkinson’s disease and healthy controls to build a big registry and study how gut function, brain signals, sleep, and circadian rhythms relate to PD symptoms.
-
Gut microbiome and Parkinson's disease: how gut bugs relate to symptoms and progression
A multi-year study will look at gut bacteria and related markers in people with Parkinson’s disease to understand how the gut-brain connection may influence symptoms and progression.
-
Gut-Brain Axis in Parkinson’s Disease: biomarkers and procedures to track progression
A patient-focused program to study how gut health and the brain interact in Parkinson’s disease using biomarkers and clinical procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.